Wendy's

Wendy's rejects $7.35-a-share bid from Trian group and adopts a poison pill

Wendy's independent directors rejected a $7.35-a-share offer from a Trian-led group and adopted a one-year shareholder rights plan. U.S. same-restaurant sales fell 5.7%, and breakfast is going location by location.